Introduction to the Department of Cardiac and Macrovascular Surgery of the Affiliated Hospital of Inner Mongolia Medical University
The Department of Cardiac and Macrovascular Surgery (formerly: Cardiothoracic Surgery, Cardiothoracic Surgery A) was founded in 1960, and is the largest center for the treatment of cardiac, thoracic and vascular diseases in Inner Mongolia Autonomous Region, and is one of the key departments of the hospital. It completes more than 500 surgeries annually. On June 1, 2007, the Cardiothoracic Surgery Department was approved by the Ministry of Health as the only heart and lung organ transplantation center in Inner Mongolia Autonomous Region. At present, there are 56 beds and an independent post-operative cardiac surgery ward (cardiac surgery ICU). Liu Zhiping, Department of Cardiac and Macrovascular Surgery, Affiliated Hospital of Inner Mongolia Medical University
The Department of Cardiac and Macrovascular Surgery has a well-trained and clinically experienced technical team. All medical staffs of the department have received comprehensive, systematic and formal medical education and high-quality cardiovascular base professional training from the state. There are 35 medical staffs (11 doctors and 24 nurses), 4 professors and chief physicians, 3 associate chief physicians, 2 attending physicians and 2 physicians. Among them, 5 have obtained doctoral degrees, 5 have obtained master’s degrees, 4 are postgraduates, 1 is a chief nurse, 8 are nurses in charge, and 1 has a master’s degree. More than 20 postgraduates have been trained in this specialty.
The Department of Cardiac and Macrovascular Surgery is the first in the autonomous region to carry out a variety of critical and complex cardiac and macrovascular surgeries, including coronary artery bypass grafting under extracorporeal circulation, non-extracorporeal circulation non-stop coronary artery bypass grafting, minimally invasive small incision coronary artery bypass grafting through the left chest; critical heart valve replacement + bypass surgery, combined heart valve replacement + atrial fibrillation radiofrequency ablation, valvuloplasty; aortic diseases (aortic aneurysm, aortic (aortic aneurysm, aortic coarctation): ascending aortic prosthetic vessel with valve tube replacement + coronary artery opening graft (Bentall’s procedure), general anesthesia deep hypothermia stop circulation aortic total arch replacement + stent elephant trunk (Sun’s procedure); aortic prosthetic vessel overlapping stent endoluminal repair (isolation); the first and second cases of allogeneic in situ heart transplantation and allogeneic lung transplantation in our department have been successful, filling the The first and second allogeneic heart transplantation and allogeneic lung transplantation in the autonomous region were successfully performed in our department, filling the gap in the autonomous region.
With the development of minimally invasive surgery, the department timely carries out all kinds of minimally invasive surgery, small incision surgery, hybrid surgery and full thoracoscopic cardiac surgery for precordial disease, valve disease, coronary heart disease, aortic coarctation and aortic aneurysm in the autonomous region.
Most of the doctors in the department have received training at the interventional treatment base of the Ministry of Health for congenital heart disease, and routinely perform interventional blocking surgery for congenital heart disease such as atrial septal defect, ventricular septal defect, patent ductus arteriosus, aortic sinus aneurysm rupture and coronary artery fistula; balloon dilation and shaping for pulmonary valve stenosis, mitral valve stenosis and aortic constriction; and artificial stent repair for aortic disease. He has performed more than 150 cases/year of intracavitary stent repair (isolation) and more than 200 cases/year of various types of interventional cardiac catheterization, coronary angiography and coronary stent placement (PCI).
In the past 5 years, we have presided over 10 scientific research projects of the Department of Science and Technology, Department of Health and Department of Education of the autonomous region, and cooperated with the National Heart Center and Beijing Fu Wai Hospital to carry out 4 related scientific research projects. The whole department has published more than 80 medical papers (1 SCI-indexed article), and the scientific research achievements have won 2 second prizes of science and technology of the Inner Mongolia Autonomous Region Medical Association.
In October 2015, the Department of Cardiac and Macrovascular Surgery became a member of the National Heart Center and Beijing Fu Wai Hospital Cardiac and Vascular Surgery Clinical Research Alliance, one of the first founding members, and also a member of Beijing Anzhen Hospital Pediatric Heart Center: a tertiary prevention and treatment base for congenital heart disease, creating a good prospect for high-level cooperation between the department and two major domestic cardiovascular disease diagnosis and treatment centers.
Cardiac macrovascular surgery special treatment items
I. Minimally invasive cardiac, thoracic and macrovascular disease diagnosis and treatment projects.
(A) Minimally invasive congenital heart disease diagnosis and treatment
1 Percutaneous (catheter) interventional occlusion: atrial septal defect, ventricular septal defect, arteriovenous catheter failure, coronary artery fistula, aortic sinus aneurysm rupture, pulmonary arteriovenous fistula interventional occlusion.
2 Minimally invasive small incisional occlusion through the chest wall: atrial septal defect, ventricular septal defect, arteriovenous catheter failure, transthoracic occlusion.
3 Trans-right thoracic lateral axillary (small) incision surgery: atrial septal defect, ventricular septal defect repair.
4 full thoracoscopic surgery: atrial septal defect, ventricular septal defect repair.
(B) Minimally invasive valvular heart disease treatment
1 Small incision valve surgery through chest wall: mitral valve replacement, aortic valve replacement, mitral valvuloplasty, tricuspid valvuloplasty.
2 Full thoracoscopic valve surgery: mitral valve replacement, mitral valvuloplasty, tricuspid valve replacement, tricuspid valvuloplasty.
(C) Minimally invasive coronary artery disease treatment
1 Small incision through the left chest: internal mammary artery-anterior descending branch of coronary artery bypass surgery.
2 Hybrid surgery: percutaneous interventional stenting (PCI) for right coronary artery and coronary artery gyrus stenosis + small left thoracic incision for internal mammary artery-anterior descending coronary artery bypass grafting. The optimal treatment plan for patients with 3-branch lesion coronary artery disease, combining all the minimally invasive advantages of cardiology and cardiac surgery and the excellent long-term patency rate of the internal mammary artery bridge.
3 Minimally invasive, interrupted small incision saphenous vein dissection.
(IV) Minimally invasive aortic disease treatment
1 Stanford type B (De Bakey type III) aortic coarctation, thoracic (abdominal) aortic aneurysm: endoluminal repair with percutaneous interventional artificial vessel overlay stent (isolation)
2 Aortic constriction: percutaneous interventional CP stent endoluminal repair
3 Stanford type A (De Bakey type I) aortic coarctation: total aortic arch replacement + stent elephant trunk surgery: Sun’s procedure
4 Aortic coarctation, thoracic (abdominal) aortic aneurysm hybridization surgery.
(E) Thoracic diseases: mediastinal tumor (thymoma, myasthenia gravis), lung, esophageal tumor, pulmonary alveolar pneumothorax, hemothorax, abscess chest total thoracoscopic surgical treatment.
II. Acute AStanford type A (De Bakey type I) thoracic aortic coarctation.
Emergency green channel surgery: general anesthesia, deep hypothermia to stop circulation (cerebral protection): ascending aortic artificial vascular replacement (or Bentall’s operation) + aortic full arch artificial vascular replacement + stent elephant trunk surgery (Sun’s operation)
Third, conventional extracorporeal circulation, surgery under non-extracorporeal circulation
1 coronary artery disease 3 branches, diffuse lesions: coronary artery bypass grafting under non-extracorporeal circulation (bypass grafting)
2 under extracorporeal circulation: repair of various congenital heart defects, correction of tetralogy of Fallot malformation, mitral, aortic, tricuspid valve replacement and plication, critical heart valve replacement + bypass surgery, combined heart valve replacement + atrial fibrillation radiofrequency ablation, ascending aortic prosthetic vessel with valve tube replacement + coronary artery opening graft (Bentall’s procedure)
IV. Thoracic surgery: resection of mediastinal tumors (thymoma, myasthenia gravis); radical surgery for chest lung and esophageal tumors, lung cancer, esophageal cancer, cardia cancer; pulmonary alveoli, pneumothorax lung repair; thoracic trauma, multiple rib fractures, hemothorax, contouring rib fixation; lobectomy for large hemoptysis with bronchial dilatation; contouring surgery for abscess thorax; correction of funnel chest.